Unotex Pharma Llp - Company Profile

It is a business services limited liability partnership based in Surat City, Gujarat, India, established in 2022.
2022 Surat City, Gujarat, India Active
Last Updated:
Access Report
About Unotex Pharma Llp

Unotex Pharma Llp, a active limited liability partnership, was established on 13 November 2022 in Surat City, Gujarat, India. Engaging in commission trade within the business services sector, it holds LLPIN: ABZ-0315. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Rajeevkumar Purshottam Kedia (Designated Partner), Priyanka Ramesh Lohia (Designated Partner), Mayank Rajeev Kedia (Designated Partner). Its latest date of accounts and solvency statement 31 March 2025. It is based at B 215, L. B. Apartment, Near Ratan Cinema, Salabatpura, Central Surat, Surat City, Gujarat, 395003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABZ-0315

  • Incorporation Date

    13 November 2022

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 3 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Unotex Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unotex Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Unotex Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Rajeevkumar Purshottam Kedia Designated Partner 11 Jun 2025 Current
Priyanka Ramesh Lohia Designated Partner 13 Nov 2022 Current
Mayank Rajeev Kedia Designated Partner 13 Nov 2022 Current
Sunitakumari Rajeevkumar Kedia Designated Partner 11 Jun 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unotex Pharma Llp.

Enhance accessibility to Unotex Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Unotex Pharma Llp revenue growth over time
Unotex Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unotex Pharma Llp?

Unlock access to Unotex Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Unotex Pharma Llp?

Unlock and access historical data on people associated with Unotex Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unotex Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unotex Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unotex Pharma Llp
Recent Activity within the Organization
  • Director Appointment

    The activity Rajeevkumar Purshottam Kedia was appointed as a Designated Partner was appointed as a Designated Partner on 11 Jun 2025 & has been associated with this company since 7 months 28 days . was completed.

  • Director Appointment

    Sunitakumari Rajeevkumar Kedia was appointed as a Designated Partner was appointed as a Designated Partner on 11 Jun 2025 & has been associated with this company since 7 months 28 days . was recorded as a recent event.

  • Annual General Meeting

    The activity Unotex Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    The activity Unotex Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    The activity Priyanka Ramesh Lohia was appointed as a Designated Partner was appointed as a Designated Partner on 13 Nov 2022 & has been associated with this company since 3 years 2 months . was completed.

  • Director Appointment

    The activity Mayank Rajeev Kedia was appointed as a Designated Partner was appointed as a Designated Partner on 13 Nov 2022 & has been associated with this company since 3 years 2 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Unotex Pharma Llp?

The LLPIN of Unotex Pharma Llp is ABZ-0315.

Where is Unotex Pharma Llp headquartered?

Unotex Pharma Llp is headquartered at B 215, L. B. Apartment, Near Ratan Cinema, Salabatpura, Central Surat, Surat City, Gujarat, 395003.

When was Unotex Pharma Llp incorporated?

Unotex Pharma Llp was incorporated on 13 November 2022.

Who are the current directors of Unotex Pharma Llp?

The current directors of Unotex Pharma Llp are

What is the primary industry of Unotex Pharma Llp?

The primary industry of Unotex Pharma Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available